Troy Quigg

Clinical trials

• The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL

  Principal investigator · Recruiting · Phase 2

  Pediatric Transplantation & Cellular Therapy Consortium

  2018–2026
• Targeted Immunotherapy After Myeloablative TBI-Based Conditioning & AlloHCT in CAYA With High Risk T-Cell ALL & Lymphoma

  Study chair · Recruiting · Phase 1

  New York Medical College

  2023–2028
• Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders

  Site PI · Recruiting · Phase 1, Phase 2

  Washington University School of Medicine

  2017–2033
• Safety Study of Unlicensed IND Cord Blood Units Manufactured by the National Cord Blood Program for Unrelated Transplantation

  Site PI · Recruiting · Phase 2

  New York Blood Center

  2012–2030